PD
Publications
144
Views
67,306
Downloads
19,898
Supervised works
8
Items per page
1 - 144 of 144
Title Published in Access level OA Policy Year Views Downloads
Domains and categories of needs in long-term follow-up of adult cancer survivors : a scoping review of systematic reviewsHealthcare
accessLevelPublic
2024 32 38
Experiences and Needs of Swiss Cancer Survivors in the Domains of Health-Related Information and the Healthcare SystemCancers
accessLevelPublic
2024 17 14
Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences studyCancer
accessLevelPublic
2024 121 24
Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal originHaematologica
accessLevelPublic
2024 68 22
Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon : a retrospective studySwiss medical weekly
accessLevelPublic
2023 33 16
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomicsInternational journal of cancer
accessLevelPublic
2023 410 49
Identification of a miRNA multi-targeting therapeutic strategy in glioblastomaCell death and disease
accessLevelPublic
2023 262 53
Cancer vaccinesCancer cell
accessLevelPublic
2022 233 97
Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancerBMC cancer
accessLevelPublic
2022 199 59
The probabilistic model of Alzheimer disease: the amyloid hypothesis revisedNature reviews. Neuroscience
accessLevelRestricted
2022 132 1
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with canceriScience
accessLevelPublic
2022 186 90
Hyaline cartilage microtissues engineered from adult dedifferentiated chondrocytes: safety and role of WNT signalingStem cells translational medicine
accessLevelPublic
2022 286 93
Linking unfolded protein response to ovarian cancer cell fusionBMC cancer
accessLevelPublic
2022 209 125
The first comprehensive genomic characterization of rectal squamous cell carcinomaJournal of gastroenterology
accessLevelPublic
2022 145 58
Modeling poliovirus infection using human engineered neural tissue enriched with motor neuron derived from embryonic stem cellsFrontiers in Cell and Developmental Biology
accessLevelPublic
2021 320 89
SARS-CoV-2 Evolution among Oncological Population: In-Depth Virological Analysis of a Clinical CohortMicroorganisms
accessLevelPublic
2021 148 82
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapyScience Immunology
accessLevelPublic
2021 379 883
Clonal Evolution of a High-Grade Pediatric Glioma With Distant Metastatic SpreadNeurology Genetics
accessLevelPublic
2021 290 62
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerCancer Cell
accessLevelPublic
2021 228 208
Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)JCI insight
accessLevelPublic
2021 212 54
Macropinocytosis requires Gal-3 in a subset of patient-derived glioblastoma stem cellsCommunications Biology
accessLevelPublic
2021 296 182
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?Cancer treatment reviews
accessLevelPublic
2021 46 25
Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatmentMolecular Oncology
accessLevelPublic
2020 389 161
An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metforminBiology (Basel)[2079-7737]
accessLevelPublic
2020 431 263
Journée du cancer : mobiliser autour de la préventionRevue médicale suisse
accessLevelPublic
2020 207 109
Immunologic clearance of a BK virus-associated metastatic renal allograft carcinomaTransplantation
accessLevelPublic
2020 296 244
Inflammation and lymphocyte infiltration are associated with shorter survival in patients with high-grade gliomaOncoImmunology
accessLevelPublic
2020 344 251
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma PatientsFrontiers in Oncology
accessLevelPublic
2020 286 100
Oncologie : naviguer la pandémie de COVID-19 et garder le capRevue médicale suisse
accessLevelPublic
2020 214 73
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger ToolHealth Science Reports
accessLevelPublic
2020 163 126
Une période de craintes et de défis : vers un monde meilleur ?Revue médicale suisse
accessLevelRestricted
2020 186 0
Stratégies de vaccination thérapeutique dans le glioblastomeMedecine Sciences
accessLevelPublic
2020 184 288
Resources-stratified guidelines for classical hodgkin lymphomaInternational Journal of Environmental Research and Public Health
accessLevelPublic
2020 360 145
Patient-Derived In Vitro Models for Drug Discovery in Colorectal CarcinomaCancers
accessLevelPublic
2020 296 157
Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasmaMolecular and Cellular Proteomics
accessLevelRestricted
2019 390 2
De sérieuses préoccupations qui ne cachent pas nos espoirsRevue médicale suisse
accessLevelPublic
2019 268 88
Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patientsNeuro-Oncology
accessLevelPublic
2019 759 373
Current strategies for vaccination in glioblastomaCurrent Opinion in Oncology
accessLevelRestricted
2019 369 5
Peptides as cancer vaccinesCurrent Opinion in Pharmacology
accessLevelRestricted
2019 381 4
Actively personalized vaccination trial for newly diagnosed glioblastomaNature
accessLevelRestricted
2019 514 12
Exploratory study of the effect of IMA950/poly-ICLC vaccination on response to bevacizumab in relapsing high-grade glioma patientsCancers
accessLevelPublic
2019 338 158
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanomaScientific Reports
accessLevelPublic
2019 232 808
Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End PointJournal of Clinical Oncology
accessLevelRestricted
2018 429 1
CAR T-Cell Therapies in Glioblastoma: A First LookClinical Cancer Research
accessLevelRestricted
2018 547 2
Onco-sexologie : un regard au cœur des patientsRevue médicale suisse
accessLevelPublic
2018 267 104
De vrais espoirs et de sérieuses préoccupationsRevue médicale suisse
accessLevelRestricted
2018 306 2
Learning from the past to design better trials in second-line treatment for mesothelioma patientsEcancermedicalscience
accessLevelPublic
2018 307 110
Médecine sexuelle et cancers : une main tendue vers l'humainRevue médicale suisse
accessLevelPublic
2018 331 154
Diagnosis and treatment of follicular lymphoma: an updateSwiss Medical Weekly
accessLevelPublic
2018 538 267
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumorsThe Journal of Pathology
accessLevelRestricted
2018 852 6
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaMolecular and Cellular Proteomics
accessLevelRestricted
2018 399 2
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma modelsOncoImmunology
accessLevelRestricted
2018 378 1
Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for CardiologistsCanadian Journal of Cardiology
accessLevelRestricted
2018 495 2
« Docteur, je jeûne lors de la chimiothérapie » : illusion ou nouvelle réalité clinique ?Revue médicale suisse
accessLevelPublic
2018 577 436
Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in SwitzerlandSwiss Medical Weekly
accessLevelPublic
2018 531 180
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III gliomaOncoImmunology
accessLevelPublic
2018 624 275
Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined ChemoradiotherapyNutrition and Cancer
accessLevelPublic
2018 428 386
Prise en charge de la sexualité chez les patients oncologiques: Un projet de recherche au sein des Hôpitaux universitaires de GenèveRevue médicale suisse
accessLevelPublic
2018 343 186
BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytomaNeurology
accessLevelPublic
2017 512 185
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapiesOncoImmunology
accessLevelRestricted
2017 595 9
A genetic polymorphism repurposes the G-protein coupled and membrane-associated estrogen receptor GPER to a transcription factor-like molecule promoting paracrine signaling between stroma and breast carcinoma cellsOncotarget
accessLevelPublic
2017 494 170
Les cancers s'envolent, les progrès suiventTribune de Geneve
accessLevelPublic
2017 357 54
Immunothérapie des gliomes : illusion ou espoir ?Bulletin du cancer
2017 381 0
Early closure of fistula using neo-adjuvant intra-arterial chemotherapy in locally advanced anal cancerDigestive and Liver Disease
accessLevelRestricted
2017 495 0
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialThe Lancet Oncology
accessLevelRestricted
2017 365 1
Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytesEMBO Reports
accessLevelRestricted
2017 548 4
ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cellsEMBO Journal
accessLevelRestricted
2017 571 10
8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016Drug Metabolism and Personalized Therapy
accessLevelRestricted
2017 517 3
Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patientsBritish Journal of Haematology
accessLevelRestricted
2017 415 0
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of GlioblastomaCancer Cell
accessLevelRestricted
2017 470 5
L'accès à l'innovationRevue médicale suisse
accessLevelRestricted
2017 321 0
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Frontiers in Oncology
accessLevelPublic
2016 476 392
Human tissue engineering allows the identification of active miRNA regulators of glioblastoma aggressivenessBiomaterials
accessLevelRestricted
2016 526 5
Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodesJournal of neuro-oncology
accessLevelPublic
2016 484 415
Outcome of patients with nonmetastatic muscle-invasive bladder cancer not undergoing cystectomy after treatment with noncisplatin-based chemotherapy and/or radiotherapy: a retrospective analysisCancer medicine
accessLevelPublic
2016 536 179
Cell-penetrating peptides-the Swiss Army knife of cancer vaccinesOncoimmunology
accessLevelPublic
2016 597 271
Progrès dans l'immunothérapie des tumeurs cérébrales : difficultés et perspectivesRevue médicale suisse
accessLevelRestricted
2016 316 2
Medulloblastoma in children and adults: one distinct disease entity?Bulletin suisse du cancer
accessLevelPublic
2016 456 48
Hypoxia and antitumor CD8(+) T cells: An incompatible alliance?OncoImmunology
accessLevelPublic
2016 447 256
Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and KillingPloS one
accessLevelPublic
2016 567 597
Ipilimumab-related hypophysitis may precede severe CNS immune attackAnnals of Oncology
accessLevelRestricted
2016 435 0
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and AdjuvantsMolecular therapy
accessLevelPublic
2016 628 283
Chimiothérapie de maintenance : futile ou utile ?Revue médicale suisse
accessLevelPublic
2015 450 157
Aggressiveness of cancer treatment in patients hospitalized in a supportive care unitSupportive care in cancer
accessLevelRestricted
2015 648 1
Phenotypic switch of CD8(+) T cells reactivated under hypoxia toward IL-10 secreting, poorly proliferative effector cellsEuropean Journal of Immunology
accessLevelRestricted
2015 509 7
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature reviewCNS oncology
2015 470 0
Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor ImmunityCancer research
accessLevelRestricted
2015 585 10
La société face au cancer : prises de conscience et initiatives citoyennesRevue médicale suisse
accessLevelPublic
2015 349 69
Lymphome cérébral : une présentation classique ?Revue médicale suisse
accessLevelPublic
2015 352 375
Immunotherapy of Brain TumorsProgress in tumor research
2015 541 0
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosomeAnnals of oncology
accessLevelPublic
2015 428 149
Création du Centre du cancer de la prostate des HUGRevue médicale suisse
accessLevelRestricted
2014 687 2
Immunotherapy for glioma: from illusion to realistic prospects?American Society of Clinical Oncology educational book
accessLevelPublic
2014 1,214 562
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaBritish journal of cancer
accessLevelPublic
2014 529 151
Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene responseInternational journal of cancer
accessLevelPublic
2014 699 391
Extrachromosomal driver mutations in glioblastoma and low-grade gliomaNature communications
accessLevelPublic
2014 706 189
Fine-needle aspiration biopsy for the diagnosis of metastatic type B thymoma to lymph nodes: A case reportDiagnostic cytopathology
accessLevelRestricted
2014 599 0
Injecting hope into brain cancer treatment: is immunotherapy the way forward?CNS Oncology
accessLevelRestricted
2014 358 0
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)European urology
accessLevelRestricted
2013 557 0
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsClinical & developmental immunology
accessLevelPublic
2013 568 554
Neuropathies associées aux paraprotéinémies (gammapathies monoclonales)Revue médicale suisse
accessLevelRestricted
2013 405 0
Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumoursPloS one
accessLevelPublic
2013 668 305
The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastomaBiomaterials
accessLevelRestricted
2013 677 6
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapyJournal of neuro-oncology
accessLevelRestricted
2013 611 0
Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapiesImmunotherapy
accessLevelPrivate
2013 501 0
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survivalNature medicine
accessLevelRestricted
2012 532 2
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-statusActa neuropathologica
accessLevelPublic
2012 537 1,017
Plasmablastic lymphoma clinically presenting in the urinary tractAnnals of diagnostic pathology
accessLevelRestricted
2012 628 0
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphomaHaematologica
accessLevelPublic
2012 553 438
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapyBrain
accessLevelPublic
2012 648 1,290
Complete remission with tyrosine kinase inhibitors in renal cell carcinomaJournal of clinical oncology
accessLevelPublic
2012 707 718
Visceral Kaposi's Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature ReviewCase reports in oncological medicine
accessLevelPublic
2012 595 279
Takotsubo syndrome secondary to adrenal adenocarcinoma: cortisol as a possible culpritAmerican journal of respiratory and critical care medicine
accessLevelRestricted
2012 624 5
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsThe oncologist
accessLevelRestricted
2012 637 0
Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal CarcinomatosisCase reports in oncology
accessLevelRestricted
2011 627 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 987 569
Soin nutritionnel intégré au soin oncologique : un besoin d'optimisationRevue médicale suisse
accessLevelPublic
2011 928 722
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 833 8
Prevention of CNS relapse in diffuse large B-cell lymphomaLancet oncology
accessLevelRestricted
2011 530 0
Recurrent Syncope due to Esophageal Squamous Cell CarcinomaCase reports in oncology
accessLevelPublic
2011 653 273
Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case reportJournal of medical case reports
accessLevelPublic
2011 589 156
Oncology ESAB 2011
accessLevelRestricted
2011 617 10
Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of gliomaGLIA
accessLevelRestricted
2010 649 0
Marker-independent identification of glioma-initiating cellsNature methods
accessLevelRestricted
2010 503 0
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98Journal of clinical oncology
accessLevelRestricted
2010 498 0
Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor developmentCancer research
accessLevelRestricted
2010 575 3
T-cell immunotherapy for malignant glioma: toward a combined approachCurrent opinion in oncology
accessLevelRestricted
2010 629 2
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaJournal of clinical oncology
accessLevelRestricted
2010 569 0
Tumors that look for their springtime in APRILCritical reviews in oncology/hematology
accessLevelRestricted
2009 622 0
Limits of CD133 as a marker of glioma self-renewing cellsInternational journal of cancer
accessLevelRestricted
2009 588 0
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvantJournal of immunotherapy
accessLevelRestricted
2009 573 0
Diagnostic precision of image-guided multisampling core needle biopsy of suspected lymphomas in a primary care hospitalBritish journal of cancer
accessLevelRestricted
2009 606 0
Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?Blood
accessLevelRestricted
2009 519 1
Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva)Dermatology
accessLevelRestricted
2008 513 0
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastomaJournal of clinical oncology
accessLevelRestricted
2008 649 0
Bevacizumab/Irinotecan. Un nouveau traitement actif dans les gliomes de haut grade récidivants : résultats préliminaires d'une étude multicentrique de l'AnocefRevue neurologique
2008 623 0
Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndromeAnnals of oncology
accessLevelRestricted
2008 565 0
Percutaneous cementoplasty in multiple myeloma: a valuable adjunct for pain control and ambulation maintenanceSupportive care in cancer
accessLevelPublic
2008 578 257
Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytesGLIA
accessLevelRestricted
2008 600 11
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answersAnnals of oncology
accessLevelRestricted
2008 520 0
Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port systemWorld journal of surgical oncology
accessLevelPublic
2008 1,123 515
Bortezomib-induced skin eruptionDermatology
accessLevelRestricted
2008 561 0
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomasJournal of pathology
accessLevelRestricted
2006 600 0
Cytomegalovirus colitis--a severe complication after standard chemotherapyActa oncologica
accessLevelRestricted
2002 587 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack